Japanese and Chinese Bridging Studies

As the pharmaceutical sector of the Japanese and Chinese healthcare industry continues to evolve, it is important that the biopharma industry executes a strategy to access it effectively. Pharmaron is well-positioned to assist our sponsors design and execute this part of their strategy as we have access to Japanese and Chinese subjects and have a deep understanding of the cultural nuances.
Our team can rapidly recruit and safely enroll qualified subjects from New York, California, Pennsylvania,  Washington, DC and Japan to support your market entry efforts. Data collected at our facility has supported multiple regulatory submissions in Japan and has been used in recent industry publications. We have successfully completed over a dozen Japanese bridging studies at our Baltimore facility.

Learn About Our Services